New York Dangerous Drugs Lawyers
Prescription Drug Attorneys in NYC
Manufacturers of prescription and over-the-counter drugs bear a responsibility to develop products that are safe for public consumption. When they fail to meet this standard, innocent lives can be needlessly shattered and lost.
The New York dangerous drugs lawyers of Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP, help people who have been harmed by dangerous drugs as well as those whose loved ones have suffered a wrongful death. We have extensive experience handling mass tort claims and individual drug liability cases for people who need skilled legal guidance.
At Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP, we have been serving the legal needs of people throughout New York and across the nation for over 30 years. We have a long record of successful results, winning settlements and jury awards for people who have been harmed by dangerous drugs and other defective products as well as those who have lost loved ones due to a wrongful death.
We are currently investigating claims for the following drugs:
- Actos causing bladder cancer
- Benicar causing sprue-like enteropathy
- Boniva causing femur fractures
- Byetta causing pancreatic cancer
- Celexa causing birth defects
- Eliquis causing Bleeding Injury
- Invokana and Farxiga causing ketoacidosis
- Januvia and Janumet causing pancreatic cancer
- Levaquin causing tendon damage
- Lyrica causing birth defects
- Medtronic Infuse Bone Growth causing sterility
- Onglyza causing heart failure
- Pradaxa causing bleeding injury
- Risperdal causing gynecomastia
- Savaysa causing bleeding injury
- Tekturna and Aliskiren causing stroke and other injury
- Testosterone drugs causing Injury
- Viagra, Cialis and Levitra causing melanoma
- Victoza causing pancreatic cancer
- Viekira Pak and Technivie causing liver damage
- Xarelto causing bleeding injury
- Zithromax causing liver injury
- Zofran causing birth defects
We have also successfully handled numerous drug liability cases, including those involving:
- Diet drugs
- Drug-induced liver damage
- Fleet Phospho Soda
- OsmoPrep and Visicol
Our lawyers will perform a rigorous investigation of the impact this injury has had on you and your family, both medically and financially. We have access to expert witnesses in pharmacology and other relevant fields who help us determine how dangerous drugs contributed to your injuries and who is liable for the damages. We offer every client personal, individual and attentive client service and a dedication to results.
What To Know Regarding Specific Drugs
Every medication prescribed potentially has specific side effects. In certain instances, drug manufacturers ignore side effect information or fail to test these drugs properly. Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP involvement in such cases include:
- Actos and bladder cancer: Actos (pioglitazone) has been linked with an increased risk of bladder cancer. Actos is a popular diabetes drug sold by Takeda Pharmaceuticals, Inc., and it is also sold in combination with other drugs as Duetact, Actoplus Met, and Actoplus Met XR.
- Generic Accutane: Isotretinoin, the generic counterpart to Accutane, is a drug that has been used to combat acne. These drugs, however, have also been linked to increased incidences of inflammatory bowel disease and other types of gastrointestinal disorders. If you or someone you know has suffered due to Accutane or Isotretinoin, it is important to explore your options with an experienced lawyer.
- Benicar: The FDA issued a safety warning in July 2013 that the blood pressure drug Benicar (olmesartan medoxomil) has been linked to sprue-like enteropathy, a condition causing horrible diarrhea and weight loss. Many doctors were unable to diagnose this condition or link it to Benicar until an article by doctors at the Mayo Clinic which reported on 22 patients who had developed this severe sprue-like enteropathy after using Benicar.
- Byetta: Mounting evidence has linked Byetta and similar drugs to increasing cases of pancreatic cancer. In 2007, that the FDA discovered pancreatitis cases in Byetta patients and proceeded with further warnings in 2008 when the drug cased a total of 6 deaths in patients who had developed pancreatitis. As a result of chronic pancreatitis risks associated with Byetta, which often go undiagnosed while the diabetes drug continues to be used, individuals may face an increased risk of developing cancer of the pancreas.
- Fosamax and bone weakening injuries: Fosamax is a bisphosphonate drug used for osteoporosis and other bone diseases. Unfortunately, the bisphosphonates in Fosamax not only help bones but can also harm them. Specifically, Fosamax can lead to weakened bones, osteonecrosis of the jaw, and fracturing of the femur.
- Invokana and Farxiga: The FDA warned in May 2015 that a commonly used newer class of type 2 diabetes drugs may cause dangerously high levels of blood acids, called ketoacidosis, that could require hospitalization. The sodium-glucose cotransporter-2 (SGLT2) inhibitors lower blood sugar by causing the kidneys to remove sugar from the body through urine. Side effects also include broken bones.
- Januvia and Janumet: Studies have shown that certain types of incretin mimetic diabetes drugs, including Januvia/ Janumet, can increase the risk of pancreatitis and pancreatic cancer. These drugs increase insulin secretion and decreasing blood sugar levels and may cause severe and deadly side effects, including acute pancreatitis. Pancreatic cancer begins in the tissues of the pancreas and is often accompanied by a poor diagnosis because of its difficulty to identify. Cancerous cells spread quickly and are hardly ever detected in their early stage which is why it is a major contributor to cancer.
- Onglyza: Onglyza is a drug used to treat type 2 diabetes manufactured by AstraZeneca. Onglyza received approval from the Food and Drug Administration (FDA) in July 2009, but has recently come under scrutiny for an increase in the incidence of heart failure in users.
- Proton Pump Inhibitors (PPI): PPIs are over the counter drugs used to treat acid reflux. A recent study published by a team at John Hopkins reports that people who use PPIs are up to 50% more likely to develop chronic kidney disease compared to those adults who do not use the antacid drugs. PPIs have been previously associated with osteoporosis, Vitamin B12 deficiency, low magnesium levels, and severe cardiovascular events.
- Stevens Johnson Syndrome: Stevens Johnson Syndrome "SJS" and Toxic Epidermal Necrolysis "TENS" are serious conditions which occur as side effects from certain drugs, particularly antibiotics and sulfa drugs. They arise from an immune disorder, commonly from these drugs: sulfonamides (antibiotics), penicillins (antibiotics), barbiturates (sedatives), lamotrigine and phenytoin (anticonvulsants). If you or someone you love has suffered drug-induced liver damage, you may be eligible to recover compensation for your financial and emotional losses.
- Tekturna and Aliskiren: Aliskiren is sold under the name Tekturna in the United States. It has been shown to cause the following problems in users including non-fatal strokes, kidney complications, hyperkalemia, hypotension (low blood pressure), and angioedema. If you have taken prescription Tekturna and are experiencing any above it is vital to seek immediate medical attention.
- Victoza: Recent studies have shown that the risk of acute pancreatitis is higher for Victoza patients than people taking other diabetes drugs. Reports were sent to the FDA's adverse-event database in 2011, in which 28 reports of pancreatic cancer were found among Victoza patients, and indicated that there is a possibility that Victoza could increase the rate of pancreatic cancer.
- Zithromax: We litigated a major case on behalf of a woman who used one Zithromax "Z-Pak" and developed liver failure. Zithromax (azithromycin) is a popular antibiotic manufactured by Pfizer that is used to treat a variety of bacterial infections. The damage can be so sudden and so severe that the liver fails and a transplant is needed.
Prescription Diet Pills
Our firm was one of the lead firms during the notorious "fen phen" litigation, when women who used that diet drug developed such serious side effects that the drug was withdrawn from the market. The injuries were damage to the valves of the heart and also pulmonary hypertension, sometimes fatal.
Now we fear that history will be repeating itself with two new drugs for weight loss which the FDA has just approved: Qsymia and Belviq. Users should be alert to the possibility of side effects. There already has been lots of litigation over side effects from Topamax, claiming that it caused numbness in the limbs. Some physicians have also cautioned that not only is Qsymia likely not to produce significant weight loss, but also may cause side effects. Research shows the medication increases heart rate, and four patients on the diet pill had nonfatal heart attacks during the research, while none of those on the placebo had heart attacks.